Targeting ATXN2 Using Antisense Oligonucleotides As a Treatment for Spinocerebellar Ataxia Type 2 (SCA2) (S30.007)

Daniel Scoles,Matthew Schneider, Pratap Meera,Karla Figueroa,Gene Hung,Frank Rigo,Frank Bennett,Thomas Otis,Stefan Pulst

Neurology（2016）

引用 0|浏览21

暂无评分

摘要

April 19, 2016April 5, 2016Free AccessTargeting ATXN2 Using Antisense Oligonucleotides as a Treatment for Spinocerebellar Ataxia Type 2 (SCA2) (S30.007)Daniel Scoles, Matthew Schneider, Pratap Meera, Karla Figueroa, Gene Hung, Frank Rigo, Frank Bennett, Thomas Otis, and Stefan PulstAuthors Info & AffiliationsApril 5, 2016 issue86 (16_supplement)https://doi.org/10.1212/WNL.86.16_supplement.S30.007 Letters to the Editor

查看译文

关键词

Ataxia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要